1)krumholz HM, et al:ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Association Task Force on performance measures(writing committee to develop performance measure on ST-elevation myocardial infarction). Circulation 113:732-761, 2006 https://doi.org/10.1161/CIRCULATIONAHA.106.172860(2022年5月閲覧)
2)krumholz HM, et al:ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures(writing committee to develop performan. Circulation 118:2596-2648, 2008 https://doi.org/10.1161/CIRCULATIONAHA.108.191099(2022年5月閲覧)
3)Jneid H,et al:2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and Non-ST-elevation myocardial infarction;A report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol 70:2048-2090, 2017 https://doi.org/10.1016/j.jacc.2017.06.032(2022年5月閲覧)
4)Schiele F, et al:Quality indicators for acute myocardial infarction;A position paper of the Acute Cardiovascular Care Association. Eur Hear J Acute Cardiovasc Care 6:34-59, 2017 https://doi.org/10.1177/2048872616643053(2022年5月閲覧)
5)Schiele F, et al:2020 Update of the quality indicators for acute myocardial infarction;A position paper of the Association for Acute Cardiovascular Care;The study group for quality indicators from the ACVC and the NSTE-ACS guideline group, Eur Hear J Acute Cardiovasc Care 10:224-233, 2021 https://doi.org/10.1093/ehjacc/zuaa037(2022年5月閲覧)
6)Drozda JP, et al:2015 ACC/AHA Focused Update of Secondary Prevention lipid performance measures;A report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol 67:558-587, 2016 https://doi.org/10.1016/j.jacc.2015.02.003(2022年5月閲覧)
7)Thygesen K, et al:Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581-1598, 2012 https://doi.org/10.1016/j.jacc.2012.08.001(2022年5月閲覧)
8)Masoudi FA, et al:ACC/AHA 2008 statement on performance measurement and reperfusion therapy;A report of the ACC/AHA Task Force on Performance Measures(Work group to address the challenges of performance measurement and reperfusion therapy). Circulation 118:2649-2661, 2008 https://doi.org/10.1161/CIRCULATIONAHA.108.191100(2022年5月閲覧)
9)Aktta S, et al:European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention;Developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology. Eur J Prev Cardiol 2021 Online ahead of print https://doi.org/10.1093/eurjpc/zwab160(2022年5月閲覧)
10)ACTION registry - GWTG:Defect free care for acute myocardial infarction specifications and testing overview http://www.ncdr.com/WebNCDR/docs/default-source/ncdr-general-documents/defect-free-care-10_4_13.pdf?sfvrsn=2(2022年5月閲覧)
11)Desai NR, et al:Trends in performance and opportunities for improvement on a composite measure of acute myocardial infarction care;Findings from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 12:1-10, 2019 https://doi.org/10.1161/CIRCOUTCOMES.118.004983(2022年5月閲覧)
12)日本循環器学会,他(編):急性冠症候群ガイドライン(2018年改訂版) https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf(2022年5月閲覧)
13)Yasuda K, et al:The current status of cardiovascular medicine in Japan - Analysis of a large number of health records from a nationwide claim-based database, JROAD-DPC. Circ J 80:2327-2335, 2016 https://doi.org/10.1253/circj.CJ-16-0196(2022年5月閲覧)